Cargando…

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination

Mass Drug Administration (MDA) for Lymphatic Filariasis (LF) elimination has been implemented worldwide and in India with a goal of eliminating the disease by 2020 and 2015 respectively. Compliance to MDA is less than adequate to achieve the goal in the desired time. This study aims to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nujum, Zinia T, Remadevi, S, Nirmala, C, Rajmohanan, K, Indu, PS, Nair, S Muraleedharan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680877/ https://www.ncbi.nlm.nih.gov/pubmed/23767017 http://dx.doi.org/10.4103/2229-5070.105175

Ejemplares similares

Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration
por: Cabral, Silvia, et al.
Publicado: (2017)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Risk Factors of Noncompliance to Preventive Mass Drug Administration for Eliminating Lymphatic Filariasis: A Case-Control Study in Jawi District, Northwest Ethiopia
por: Mihretu, Fetene, et al.
Publicado: (2022)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya
por: Njomo, Doris W., et al.
Publicado: (2012)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
por: Ranganath, TS, et al.
Publicado: (2012)

Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis
por: Maroto-Camino, Carmen, et al.
Publicado: (2019)

Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana
por: Niles, Reza A., et al.
Publicado: (2021)

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
por: Amarillo, Maria Lourdes E, et al.
Publicado: (2008)

An Evaluation of Coverage and Compliance of Mass Drug Administration 2006 for Elimination of Lymphatic Filariasis in Endemic Areas of Gujarat
por: Kumar, Pradeep, et al.
Publicado: (2008)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Epidemiological and Entomological Evaluations after Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria
por: Richards, Frank O., et al.
Publicado: (2011)

Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India
por: Ghosh, Santanu, et al.
Publicado: (2013)

Coverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India
por: Roy, Rabindra Nath, et al.
Publicado: (2013)

Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India
por: Kumar, Dhananjay, et al.
Publicado: (2023)

Global Elimination of Lymphatic Filariasis: A “Mass Uprising of Compassion”
por: Addiss, David G.
Publicado: (2013)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
por: Bhullar, Navneet, et al.
Publicado: (2010)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
por: Hussain, Mohammad A, et al.
Publicado: (2014)

Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya
por: Njomo, Doris W., et al.
Publicado: (2014)

Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection
por: Khan, Abdul Mabood
Publicado: (2018)

Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
por: Taleo, Fasihah, et al.
Publicado: (2017)

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study
por: Banerjee, Sitikantha, et al.
Publicado: (2019)

Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
por: Modi, Anjali, et al.
Publicado: (2021)

The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
por: Burkot, TR, et al.
Publicado: (2006)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
por: Khaemba, Christabel, et al.
Publicado: (2021)

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
por: Rebollo, Maria P., et al.
Publicado: (2015)

Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
por: Toothong, Tanaporn, et al.
Publicado: (2015)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India
por: Modi, Anjali, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qiq67nstjopfgpto4crrte2ffc